Steffi Oesterrich

64PUBLICATIONS

237CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Cancer diagnosis

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (64)

Sort by Publication Date:

|May 20, 2026

RET signaling as a mediator of estrogen receptor positive breast cancer brain metastasis.

|Apr 07, 2026

Identification and credentialing of patient-derived xenograft models of invasive lobular carcinoma.

Jagmohan Hooda, Jennifer M Atkinson, Osama Shiraz Shah

|Mar 19, 2026

Use of ctDNA in Older Women with ER+ Breast Cancer to Facilitate Surgical De-escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies.

Neil Carleton, Alexander C Chang, Fangyuan Chen

|Nov 14, 2025

Mixed Molecular Subtypes Coexist in Estrogen Receptor Heterogeneous Primary Breast Cancers.

Julia Foldi, Kaitlyn Xiong, Matthew Liu

|Sep 10, 2025

SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer.

Rikkemaja Isahbell J Møldrup, Mikkel G Terp, Simon T Jakobsen

|Jun 27, 2025

p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2<sup>+</sup> breast cancer that limits trastuzumab deruxtecan efficacy.

Dong Hu, Xiaoshuang Lyu, Zheqi Li

Pageof 11

Frequent Collaborators

38 joint publications

Adrian V Lee

11 joint publications

Jennifer M Atkinson

10 joint publications

Neil M Carleton

Matthew Sikora

Tullia C Bruno

Julia Foldi

Rohit Bhargava

Zheqi Li

Jagmohan Hooda

Fangyuan Chen

Frequent Collaborators

38 joint publications

Adrian V Lee

11 joint publications

Jennifer M Atkinson

10 joint publications

Neil M Carleton

7 joint publications

Matthew Sikora